Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85

Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916

ceritinib fentanyl

increases exposure

Severe Theoretical

ceritinib opioids

increases exposure

Severe Theoretical

ceritinib warfarin

increases exposure

Severe Theoretical

chloroprocaine sulfonamides

decreases effects

Severe Theoretical

chloroquine agalsidasealfa

decreases effects

Severe Theoretical

chloroquine agalsidasebeta

decreases effects

Severe Theoretical

chloroquine intradermal

decreases efficacy

Severe Study

chloroquine penicillamine

increases risk of haematologicaltoxicity

Severe Theoretical

chloroquine rabiesvaccine

decreases efficacy

Severe Study

chloroquine remdesivir

decreases effects

Severe Theoretical

chlorpromazine metyrapone

decreases effects

Severe Theoretical

ciclosporin cholicacid

affects concentration

Severe Study

ciclosporin dabigatran

increases exposure

Severe Study

ciclosporin darifenacin

increases exposure

Severe Theoretical

ciclosporin fidaxomicin

increases exposure

Severe Study

ciclosporin mifamurtide

decreases efficacy

Severe Theoretical

ciclosporin rosuvastatin

increases exposure

Severe Study

ciclosporin tacrolimus

increases concentration

Severe Study

ciclosporin thrombininhibitors

increases exposure

Severe Study

ciclosporin tofacitinib

increases exposure

Severe Study

ciclosporin voxilaprevir

increases concentration

Severe Study

cimetidine anthracyclines

increases exposure

Severe Study

cimetidine epirubicin

increases exposure

Severe Study

cimetidine fampridine

increases concentration

Severe Theoretical

ciprofloxacin tizanidine

increases exposure

Severe Study

clarithromycin acalabrutinib

increases exposure

Severe Study

clarithromycin alprazolam

increases exposure

Severe Study

clarithromycin antihistamines,non-sedating

increases exposure

Severe Study

clarithromycin avapritinib

increases exposure

Severe Study

clarithromycin benzodiazepines

increases exposure

Severe Study

clarithromycin beta

increases exposure

Severe Study

clarithromycin ergometrine

increases risk of ergotism

Severe Theoretical

clarithromycin ergotamine

increases risk of ergotism

Severe Theoretical

clarithromycin everolimus

increases exposure

Severe Study

clarithromycin finerenone

increases exposure

Severe Study

clarithromycin irinotecan

increases risk of toxicity

Severe Study

clarithromycin ivabradine

increases exposure

Severe Study

clarithromycin lapatinib

increases exposure

Severe Study

clarithromycin lurasidone

increases exposure

Severe Study

clarithromycin mineralocorticoidreceptorantagonists

increases exposure

Severe Study

clarithromycin mizolastine

increases exposure

Severe Study

clarithromycin mobocertinib

increases exposure

Severe Study

clarithromycin nilotinib

increases exposure

Severe Study

clarithromycin phosphodiesterasetype-

increases exposure

Severe Study

clarithromycin pimozide

increases exposure

Severe Study

clarithromycin quetiapine

increases exposure

Severe Study

clarithromycin ranolazine

increases exposure

Severe Study

clarithromycin reboxetine

increases exposure

Severe Study

clarithromycin regorafenib

increases exposure

Severe Study

clarithromycin rimegepant

increases exposure

Severe Study

Prev 1 2 3 4 5 ... 126 Next

6278 interactions

Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.